title: Peptide Immunotherapy in Vaccine Development: From Epitope to Adjuvant.
abstract: Vaccines are designed to educate the host immune system to prevent infectious disease or to fight against various diseases such as cancers. Peptides were first employed to provide specific immune responses while minimizing unintended allergenic or reactogenic adverse effects. Discoveries of virus or cancer-specific antigens and the advanced knowledge of immunology accelerate the peptide vaccine development. Despite the overwhelming research pipelines, a very few of them reached to market approvals or phase III clinical trials, because of the lack of efficacy. Several strategies for the next generation peptide vaccines are devised to overcome the weak immunogenicity and the poor delivery. In this review, we discuss the new promising strategies of peptide vaccine development which are recently developed in preclinical and/or clinical stage focusing the roles of peptides in the vaccine formulation from epitope to adjuvant. Additionally, we discuss the future perspectives of peptide vaccine and immunotherapy.
authors.affiliation: Research and Development Center, Peptron, Inc., Daejeon, South Korea.
authors.forename: Hyun
authors.initials: H
authors.lastname: Yang
authors.affiliation: Research and Development Center, Peptron, Inc., Daejeon, South Korea. Electronic address: dskim@peptron.co.kr.
authors.forename: Dong Seok
authors.initials: DS
authors.lastname: Kim
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D000939:Epitopes / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D010455:Peptides / Q000276:immunology*; D014612:Vaccines / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D000939:Epitopes; D010455:Peptides; D014612:Vaccines
keywords: Adjuvant; Delivery; Epitope; Peptide; Vaccine